Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

681
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
681
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

2.1K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
2.1K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

797
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
797
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

922
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
922
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen01:16

Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen

3.5K
Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
3.5K
Oxygen Delivering System I: Nasal Cannula and Face Mask01:26

Oxygen Delivering System I: Nasal Cannula and Face Mask

2.5K
The human body requires oxygen to function, and when the natural process of respiration is hindered, external devices, including the following, are needed to help deliver this vital gas.
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Effectiveness and Safety of Extrafine Triple Therapy in COPD Patients with Comorbid and Cardiovascular Conditions.

International journal of chronic obstructive pulmonary disease·2026
Same author

Clinical phenotyping of asthma patients with elevated sputum eosinophils and low blood eosinophils: a post-hoc analysis of the multicentre ATLANTIS cohort.

EBioMedicine·2026
Same author

Re-evaluating the role of reference equations in pulmonary function test interpretation.

The European respiratory journal·2026
Same author

Inhaled Triple Therapy in Symptomatic Smokers with Preserved FEV1/FVC ratio: The CHRONOS Clinical Trial.

American journal of respiratory and critical care medicine·2026
Same author

Distal Airway Inflammation Is Linked to Small Airway Dysfunction in Asthma.

Medical sciences (Basel, Switzerland)·2026
Same author

A Real-World Evaluation of Therapeutic Inertia in Patients with Severe Uncontrolled Chronic Obstructive Pulmonary Disease.

International journal of chronic obstructive pulmonary disease·2026

Related Experiment Video

Updated: Apr 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.7K

Optimizing Respiratory Care with NEXThaler: Bridging Technology and Treatment.

Omar Usmani1,2, Fulvio Braido3,4, Daiana Stolz5,6

  • 1National Heart and Lung Institute (NHLI), Royal Brompton Hospital (RBH) and St Mary's Hospital London, Imperial College London, London, UK.

Medical Devices (Auckland, N.Z.)
|April 14, 2026
PubMed
Summary

The NEXThaler breath-actuated dry powder inhaler (DPI) offers effective delivery of extrafine inhaled corticosteroids (ICS) and bronchodilators for asthma and COPD. Its design improves lung deposition, adherence, and patient satisfaction, representing a patient-friendly respiratory care option.

Keywords:
NEXThalerasthmachronic obstructive pulmonary diseasedry powder inhalerextrafine formulation

More Related Videos

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

5.9K
Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide
04:16

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide

Published on: January 30, 2026

960

Related Experiment Videos

Last Updated: Apr 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.7K
A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

5.9K
Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide
04:16

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide

Published on: January 30, 2026

960

Area of Science:

  • Respiratory Medicine
  • Pharmacology
  • Biomedical Engineering

Background:

  • Inhaler device choice critically impacts asthma and COPD management, affecting treatment efficacy and patient adherence.
  • Extrafine particle formulations delivered via breath-actuated devices enhance lung deposition, particularly in small airways.

Purpose of the Study:

  • To review the design features and clinical performance of the NEXThaler breath-actuated dry powder inhaler (DPI).
  • To evaluate the efficacy, safety, and usability of the NEXThaler DPI for delivering inhaled corticosteroids (ICS) and bronchodilators in chronic respiratory diseases.

Main Methods:

  • Comprehensive analysis of peer-reviewed clinical and preclinical studies on the NEXThaler DPI.
  • Review of studies focusing on device design, lung deposition, clinical trials, and real-world evidence.

Main Results:

  • The NEXThaler DPI features a breath-actuated mechanism, flow-independent dosing, and a triple feedback system for enhanced usability.
  • Extrafine particle delivery (<2 µm) improves peripheral lung deposition and allows for potentially lower ICS doses with maintained efficacy.
  • Clinical studies confirm efficacy and safety in asthma and COPD, demonstrating noninferiority to other inhalers and improved lung function, symptom control, and adherence.

Conclusions:

  • The NEXThaler DPI is a clinically validated, patient-friendly device for inhaled therapies in asthma and COPD.
  • Its technological innovations, including extrafine particle delivery and enhanced usability, support improved patient outcomes and adherence.
  • The propellant-free design also offers environmental benefits in respiratory care.